CPAS: A trans-omics pathway analysis tool for jointly analyzing DNA copy number variations and mRNA expression profiles data

Pathway-based analysis approaches provide additional insights into the pathogenesis of complex diseases. Copy number variations (CNVs) play an important role in gene expression regulation. Joint pathway analysis of CNVs and gene expression data should provide more useful information for revealing the molecular mechanism of complex diseases. To implement trans-omics pathway analysis of genome-wide CNVs and mRNA expression profiles data, we extended the gene set enrichment analysis algorithm and developed a flexible trans-omics pathway analysis tool CPAS. CPAS was developed by C to interface with R for efficient data analysis. CNV-gene and pathway-gene annotation files derived from public database were included in CPAS. We hope that CPAS could help to identify disease-relevant biological pathways that were undetectable using traditional single-omic analysis approaches.

[1]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[2]  Jian Li,et al.  Integrative analysis of GWASs, human protein interaction, and gene expression identified gene modules associated with BMDs. , 2014, The Journal of clinical endocrinology and metabolism.

[3]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Xiong Guo,et al.  Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease. , 2006, The Journal of rheumatology.

[5]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[6]  Hong-Wen Deng,et al.  Biological Pathway‐Based Genome‐Wide Association Analysis Identified the Vasoactive Intestinal Peptide (VIP) Pathway Important for Obesity , 2010, Obesity.

[7]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[8]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[9]  John K Wiencke,et al.  A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression , 2014, Epigenetics.

[10]  M. Hinsenkamp,et al.  Kashin-Beck disease , 2001, International Orthopaedics.

[11]  Tie-Lin Yang,et al.  Pathway-Based Genome-Wide Association Analysis Identified the Importance of Regulation-of-Autophagy Pathway for Ultradistal Radius BMD , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Xiong Guo,et al.  Genome-Wide Gene Expression Analysis Suggests an Important Role of Hypoxia in the Pathogenesis of Endemic Osteochondropathy Kashin-Beck Disease , 2011, PloS one.

[13]  Chen Duan,et al.  Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. , 2010, Arthritis and rheumatism.

[14]  Ying Zhang,et al.  A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration , 2014, Cell and Tissue Research.

[15]  André Scherag,et al.  Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis , 2010, Human molecular genetics.

[16]  Yan Guo,et al.  Copy number variation on chromosome 10q26.3 for obesity identified by a genome-wide study. , 2013, The Journal of clinical endocrinology and metabolism.